| 0 (0%) | 10-20 10:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 110.9  |
1-year : | 129.53 |
| Resists | First : | 94.94 |
Second : | 110.9 |
| Pivot price | 88.66  |
|||
| Supports | First : | 88.32 |
Second : | 84.23 |
| MAs | MA(5) : | 92.4 |
MA(20) : | 88.25 |
| MA(100) : | 96.54 |
MA(250) : | 85.53 |
|
| MACD | MACD : | 0.1 |
Signal : | -1 |
| %K %D | K(14,3) : | 92.5 |
D(3) : | 93.5 |
| RSI | RSI(14): 62.3 |
|||
| 52-week | High : | 110 | Low : | 68.48 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ CVS ] has closed below upper band by 2.7%. Bollinger Bands are 12.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 92.8 - 93.24 | 93.24 - 93.65 |
| Low: | 89.89 - 90.4 | 90.4 - 90.88 |
| Close: | 91.84 - 92.64 | 92.64 - 93.4 |
Tue, 20 Oct 2026
CVS MinuteClinic Opens New Walk-In Medical Clinic in Swampscott - Swampscott Tides
Tue, 20 Oct 2026
Don't Sleep on the CVS Beauty Section—17 Items I Swear By, From French Skincare to Designer Perfume - Who What Wear
Mon, 19 Oct 2026
Patrick Ta Beauty Sues CVS, Distributor Over Unauthorized Product Sales - Beauty Independent
Tue, 13 Oct 2026
CVS Pharmacy reaches $315M settlement with Justice Department over controlled substance prescriptions - Fox Business
Tue, 13 Oct 2026
CVS to pay $315M settlement over allegations of illegally filling opioid prescriptions - The Hill
Tue, 13 Oct 2026
CVS settles US Justice Department case over opioid prescriptions for $315 million - Reuters
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1,280 (M) |
| Shares Float | 1,280 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 90.8 (%) |
| Shares Short | 16,470 (K) |
| Shares Short P.Month | 18,110 (K) |
| EPS | 3.79 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 62.36 |
| Profit Margin | 1.1 % |
| Operating Margin | 3.8 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | 6.1 % |
| Qtrly Rev. Growth | 7 % |
| Gross Profit (p.s.) | 43.99 |
| Sales Per Share | 322.37 |
| EBITDA (p.s.) | 13.03 |
| Qtrly Earnings Growth | 188.8 % |
| Operating Cash Flow | 14,780 (M) |
| Levered Free Cash Flow | 8,080 (M) |
| PE Ratio | 24.74 |
| PEG Ratio | 0.2 |
| Price to Book value | 1.5 |
| Price to Sales | 0.29 |
| Price to Cash Flow | 8.14 |
| Dividend | 0.67 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|